The impact of the COVID-19 pandemic on an international rehabilitation study in MS: the CogEx experience.
Ontology highlight
ABSTRACT: Pandemic restrictions have led to changes in therapy plans and disrupted rehabilitation services for people with multiple sclerosis. CogEx is an international, multicentre MS dual-intervention (cognitive rehabilitation, aerobic exercise) randomized, controlled rehabilitation trial confined to people with progressive disease. The primary outcome is cognition (processing speed).There are 11 treatment sites in six countries with participants required to make 27 site visits over 12 weeks. Collectively, the large, in-person demands of the trial, and the varying international policies for the containment of COVID-19, might disproportionately impact the administration of CogEx. During the first lockdown, all centres closed on average for 82.9 (SD = 24.3) days. One site was required to lockdown on
SUBMITTER: Feinstein A
PROVIDER: S-EPMC8570234 | biostudies-literature | 2022 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA